Tissue Regenix raises £40m at 16.6% discount

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Follow-ons and Rights issues

Tissue Regenix raises £40m at 16.6% discount

Aidan Gregory
July 24, 2017 03:00 pm

Tissue Regenix Group, the UK regenerative medical technology company owned by IP Group, has issued £40m of shares to finance its acquisition of CellRight Technologies in the US.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityUKEuropeFollow-ons and Rights issuesEMEAJefferies LLC
AG
Aidan Gregory
Gift this article